Eleotin Pango
Eleotin Pango, licence 80065486: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Eastwood Bio-Medical Research Inc.
- NPN or DIN-HM
- 80065486
- Status
- Active licence
- Licence date
- 25 November 2015
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
règlement (UE) 2022/63. Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Dioxyde de titane | 4.5 Pour cent | Not calculated |
| Oxyde de zinc | 4.5 Pour cent | Not calculated |
Non-medicinal ingredients
Beurre de Cacao, Poudre de feuilles d'Aloe Barbadensis, Huile essentielle d' Eucalyptus Citriodora, Bentonite
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Crème | 1.0 Tous les jours |
Uses authorised in Canada
Sunscreen Lotion for Face & Body SPF 18 UVA/UVB protection.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Consult a health care practitioner prior to use on children less than 6 months of age. .
- Précautions et mises en garde
Sun Alert: The sun may cause sunburn, premature aging of the skin and skin cancer. Avoiding the sun, wearing protective clothing and regular use of the sunscreens over the years may reduce the chance of these harmful effects. Caution: Discontinue use if skin irritation develps or increases. If irritation persists, consult a health cae practioner. Avoid contact with eyes. If contact occurs, rinse thoroughly with water. For external use only. Keep out of reach of children. Consults a health care practitioner prior to use on children less that six months of age. .
Source
Official Health Canada record, licence 80065486
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.